Neurological Outcomes of Primary Intracerebral Haemorrhage

Neurological Outcomes of Primary Intracerebral Haemorrhage Admitted in Intensive Care Unit at the University Hospital of Grenoble Alpes

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03995940

Acronym

HIP-REA

Enrollment

Registered

2019-06-24

Start date

2019-04-30

Completion date

2020-01-31

Last updated

2019-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Hemorrhage, Hypertensive

Brief summary

The main objective of this study is to determine the one-year neurological outcome of patients admitted to an intensive care unit (ICU) for a primary and spontaneous supratentorial intracerebral hemorrhages (ICH).

Detailed description

ICH represent a diagnostic and therapeutic emergency. ICH account for 20% of strokes with a one-year mortality of more than 45% and an uncertain neurological outcome. For ICH patients, the main initial challenge is to determine the long term neurological outcomes and adapt the therapeutic strategy. The majority of primary and spontaneous ICH studies involve patients in stroke units. The study is an observational type 3 research with all the patients admitted in all the University Hospital of Grenoble Alpes ICUs between July 2012 and July 2017 for a primary and spontaneous supratentorial ICH

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Admission in one of the four University Hospital of Grenoble Alpes ICUs between July 2012 and July 2017 for primary and spontaneous supratentorial ICH. * Not opposed to participate in a research protocol (asked by phone call)

Exclusion criteria

* Pediatric patient * Infra-tentorials ICH * No spontaneous ICH (after head trauma) * Secondary ICH (anevrisum, arteriovenous malformation, tumor, hemorrhagic transformation, vascularitis) * Persons referred to in Articles L1121-5 to L1121-8 of the french public health code

Design outcomes

Primary

Measure	Time frame	Description
Neurological outcomes	One year after the stroke	Collection of the Modified Ranking Scale (mRS) at one year by patients phone call or with the medicale file.

Countries

France

Contacts

Primary ContactCatherine Portal

bportal@chu-grenoble.fr+33.4.76.76.67.29

Backup ContactCamille Ducki

ArcPromoteur@chu-grenoble.fr

Outcome results